Physician profile
Sunil Malhotra
NPI 1841369907
$645.58
in general payments reported to CMS, 2019-2025
9 companies · $18.38 in 2025
The $18.38 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $148 · 2020: $25.22 · 2022: $346 · 2023: $92.05 · 2024: $15.85 · 2025: $18.38.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $126.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $126.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $151.37 | 2022 | |
| Medtronic, INC. | $151.36 | 2022 | |
| Chiesi USA, INC. | $147.74 | 2019 | |
| Philips North America LLC | $79.27 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $34.23 | 2024-2025 | Xifaxan |
| Edwards Lifesciences Corporation | $30.42 | 2022 | |
| Medtronic Vascular, INC. | $25.22 | 2020 | |
| Boston Scientific Corporation | $13.19 | 2022 | |
| Pfizer INC. | $12.78 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sunil Malhotra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.